Richard Cross

Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers

Indra Neil Guha, Julie Parkes, Paul Roderick et al. · Hepatology · 2007 · 732 citations · Full text

Performance of ELF Serum Markers in Predicting Fibrosis Stage in Pediatric Non-Alcoholic Fatty Liver Disease

Valério Nobili, Julie Parkes, GianFranco Bottazzo et al. · Gastroenterology · 2008 · 262 citations

Obesity, Metabolic Syndrome, Body Composition +13

Enhanced Liver Fibrosis (ELF) test accurately identifies liver fibrosis in patients with chronic hepatitis C

Julie Parkes, Indra Neil Guha, Paul Roderick et al. · Journal of Viral Hepatitis · 2010 · 172 citations

Enhanced Liver Fibrosis, Liver Fibrosis, Elf Test +20

Role of a cirrhosis risk score for the early prediction of fibrosis progression in hepatitis C patients with minimal liver disease

Eric Trépo, Andrej Potthoff, Pierre Pradat et al. · Journal of Hepatology · 2010 · 59 citations

Cirrhosis Risk Score, Epidemiology, Hepatology +15

Validity of noninvasive markers of methotrexate-induced hepatotoxicity: a retrospective cohort study

C.L. Martyn‐Simmons, William Rosenberg, Richard Cross et al. · British Journal of Dermatology · 2014 · 56 citations